NEW YORK, Sept. 18 – British bioinformatics company Proteom announced Tuesday a collaboration with Dartmouth Medical School to identify and develop peptides that can interrupt the process of apoptosis.

Under the terms of the deal, Proteom will contribute its expertise in designing peptides, while Dartmouth will provide its knowledge about the protein pathways involved in cell death.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.